BridgeBio Receives Almost 300 Million for Continued Rare Disease Research

About BridgeBio Pharma BridgeBio Pharmaceuticals was created in 2015 by veterans from the fields of academia and biotechnology. The company focuses on the development of new therapeutic treatments for genetic…

Continue Reading BridgeBio Receives Almost 300 Million for Continued Rare Disease Research
Close Menu